Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
about
Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP)Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula).High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production.Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance.Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice.Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus Patients with and without Nephropathy.Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetesSerum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes.Small dense low-density lipoprotein as a potential risk factor of nephropathy in type 2 diabetes mellitus.Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?Correlation of vascular endothelial function and coagulation factors with renal function and inflammatory factors in patients with diabetic nephropathy
P2860
Q34408854-1BC81C50-1642-47F2-8684-556375395934Q34521231-D94F8A7A-F331-42AB-8808-C6D771A91974Q35055477-621DEDCE-F1B3-4F98-87EF-FC76AB06DA06Q35126070-FEEC9546-F166-4BE0-9F26-8F7162BD9F63Q35536459-7D12795A-A0E9-4470-A2B0-2381D7926226Q36064668-8B5722A2-E7E9-4B76-AE7F-1FF3B73ADD33Q36518342-E57265CA-E945-456C-9C5B-4EDFEDAEED56Q36589001-C6B5CF91-E9FF-4CC6-8419-E013ADFF197DQ36783350-7018555A-0660-4F12-B0AA-CCA1F83AF833Q37139501-61142196-5747-4EC7-86EA-3BA05C09A04DQ37319187-F894BCEB-57ED-4BBD-B209-717D6B7A7E18Q37670695-55ADD684-F48D-4CA3-935F-5FAB371987C3Q41932191-6E03E19B-8349-4AF4-8749-9F8EB1779F92Q58552449-DEEDD586-696C-421F-98CA-E534890DE5A3
P2860
Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Potential influence of lipids ...... tal data and clinical studies.
@ast
Potential influence of lipids ...... tal data and clinical studies.
@en
type
label
Potential influence of lipids ...... tal data and clinical studies.
@ast
Potential influence of lipids ...... tal data and clinical studies.
@en
prefLabel
Potential influence of lipids ...... tal data and clinical studies.
@ast
Potential influence of lipids ...... tal data and clinical studies.
@en
P1476
Potential influence of lipids ...... ntal data and clinical studies
@en
P2093
P304
P577
2000-09-01T00:00:00Z